Dana-Farber Cancer Institute ( Site 0015)

Boston, Massachusetts 02215

1 studies enrolling now · 1 studies all time

What they study most

Ovarian Cancer Recurrent

Studies at this site

• A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) — Recruiting now